Immunome Announces Promotion of Max Rosett to Chief Financial Officer

Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the promotion of Max Rosett to Chief Financial Officer,...

Related Keywords

Boston ,Massachusetts ,United States ,Clay Siegall ,Yale University ,Nasdaq ,Boston Consulting Group ,Twitter ,Immunome Inc ,Linkedin ,Securities Exchange ,Google ,Georgia Institute Of Technology ,Max Rosett ,Chief Financial Officer ,Executive Vice President ,Interim Chief Financial Officer ,Chief Executive ,Acting Chief Operating Officer ,Research Bridge Partners ,Computer Science ,Georgia Institute ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Report ,